s6y Guardion Health Sciences, Inc. CORRESP

Guardion Health Sciences, Inc. CORRESP, filed Dec 21, 2016: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

 

GUARDION HEALTH SCIENCES, INC.

15150 Avenue of Science, Suite 200

San Diego, CA 92128

 

 

December 21, 2016

Irene Paik, Esq.

Division of Corporate Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

  Re: Guardion Health Sciences, Inc.
    Amendment No. 3 to Registration Statement on Form S-1
    Last Filed December 16, 2016
    File No. 333-209488

 

Accelerated Request

 

Requested Date: December 27, 2016
Requested Time: 10:00 A.M. Eastern Time

 

 

Dear Ms. Paik:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Guardion Health Sciences, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-referenced Registration Statement on Form S-1 effective as of the Requested Date and Requested Time set forth above, or as soon thereafter as is possible.

 

In connection with the foregoing request for acceleration of effectiveness, the Company hereby acknowledges the following:

 

lshould the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

lthe action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

 

 

 

U.S. Securities and Exchange Commission

December 21, 2016

Page 2

 

lthe Company may not assert staff comments or the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

The Company requests that it be notified of such effectiveness by telephone call to Elliot Lutzker (646-428-3210).

 

  GUARDION HEALTH SCIENCES, INC.
     
     
  By: /s/ Michael Favish
    Michael Favish
    Chief Executive Officer